Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

1.1K
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.1K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

2.0K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.0K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

384
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
384
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

1.0K
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
1.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artelon Graft Augmentation in Revision Anterior Cruciate Ligament Reconstruction: Surgical Technique Guide.

Journal of orthopaedic case reports·2026
Same author

Control of nocturnal hypoglycemia by CGM-based AI-enabled nocturnal hypoglycemia prediction: A retrospective analysis of real-world data.

Diabetes research and clinical practice·2026
Same author

In Support of Venous Glucose as a Reference Matrix for Evaluating Continuous Glucose Monitoring Accuracy.

Journal of diabetes science and technology·2026
Same author

Open Modified Gallie Procedure for Chronic Anterior Shoulder Instability.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2025
Same author

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial.

Lancet (London, England)·2025
Same author

Accuracy of the 15.5-Day G7 iCGM in Adults with Diabetes.

Diabetes technology & therapeutics·2025
Same journal

A Pilot Study on Disposal Practices and Environmental Awareness of Insulin-Related Devices Among People With Diabetes.

Journal of diabetes science and technology·2026
Same journal

Quality of In-Use Insulin Under Real-World Storage Conditions in Mwanza, Tanzania.

Journal of diabetes science and technology·2026
Same journal

Continuous Glucose Monitoring Metrics for Predicting Adverse Neonatal Outcomes in Individuals Undergoing Gestational Diabetes Screening.

Journal of diabetes science and technology·2026
Same journal

Diabetes Technologist: Optimal Use of Technology in Everyday Practice.

Journal of diabetes science and technology·2026
Same journal

AI-Driven Diabetes Care and Its Relevance in the Philippine Context: Opportunities and Persistent Digital Barriers.

Journal of diabetes science and technology·2026
Same journal

Ease of Use, Ease of Learning, and Convenience of the CagriSema Dual-Chamber Pen: Results From a Usability Study in Adults With Overweight, Obesity, or Type 2 Diabetes.

Journal of diabetes science and technology·2026
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Usability and training differences between two personal insulin pumps.

Noel E Schaeffer1, Linda J Parks2, Erik T Verhoef2

  • 1Tandem Diabetes Care, Inc, San Diego, CA, USA nschaeffer@tandemdiabetes.com.

Journal of Diabetes Science and Technology
|October 16, 2014
PubMed
Summary
This summary is machine-generated.

The Tandem Diabetes Care t:slim insulin pump demonstrated significant advantages over the Medtronic MiniMed Paradigm Revel pump, requiring less training time and fewer user errors for diabetes management.

Keywords:
engineering psychologyhuman factorsindustrial psychologyinsulin pumpmedical device safetypsychologyresearchuse erroruser experience researchuser-centered design

More Related Videos

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
05:52

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster

Published on: June 30, 2011

19.3K
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

16.0K

Related Experiment Videos

Last Updated: Apr 22, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
05:52

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster

Published on: June 30, 2011

19.3K
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

16.0K

Area of Science:

  • Biomedical Engineering
  • Human-Computer Interaction
  • Diabetes Technology

Background:

  • Insulin pumps are critical for diabetes management.
  • Comparing usability and training of different insulin pump models is essential for user adoption and safety.

Purpose of the Study:

  • To compare the usability and training effectiveness of the Medtronic MiniMed Paradigm Revel Insulin Pump and the Tandem Diabetes Care t:slim Insulin Pump.
  • To identify differences in training time, task performance, and user satisfaction between the two insulin pumps.

Main Methods:

  • A between-subjects experimental design with 72 participants managing diabetes with multiple daily insulin injections.
  • Participants were randomized to use either the Revel or t:slim pump in a simulated environment.
  • Key metrics included training time, task completion rates, error occurrences, and System Usability Scale (SUS) scores.

Main Results:

  • The t:slim pump group showed a statistically significant 27% reduction in training time compared to the Revel group.
  • Participants using the t:slim pump exhibited a 65% reduction in use error rates.
  • The t:slim pump demonstrated statistically significant advantages in both training and usability.

Conclusions:

  • The t:slim insulin pump offers superior training efficiency and a more intuitive user experience compared to the Revel pump.
  • Design elements such as optimized information architecture and active error prevention likely contribute to the t:slim's improved usability and safety.